Singapore markets open in 6 hours 2 minutes

Vicapsys Life Sciences, Inc. (VICP)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.44400.0000 (0.00%)
As of 10:29AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 14.24M
Enterprise value 14.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.02
Enterprise value/revenue 0.43
Enterprise value/EBITDA -55.20

Trading information

Stock price history

Beta (5Y monthly) -5.59
52-week change 3-55.60%
S&P500 52-week change 326.94%
52-week high 33.0000
52-week low 30.4440
50-day moving average 30.9904
200-day moving average 31.7905

Share statistics

Avg vol (3-month) 3126
Avg vol (10-day) 3N/A
Shares outstanding 532.07M
Implied shares outstanding 632.07M
Float 813.85M
% held by insiders 156.82%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 302 Nov 2017
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 302 Nov 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-141.85%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -640.86k
Net income avi to common (ttm)-1.08M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)53.53k
Total cash per share (mrq)0
Total debt (mrq)307.25k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.14
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-332.58k
Levered free cash flow (ttm)-86.89k